The motivational properties of the non-peptide delta-opioid receptor agonists BW373U86 and SNC 80 were investigated using the place-conditioning paradigm. BW373U86 (0.5 1.0 mg/kg s.c.) and SNC 80 (1.25 5.0 mg/kg s.c.) elicited significant preference for the drug-paired compartment, in a dose-related fashion. Naltrindole (5.0 mg/kg s.c.) pretreatment, while failing to modify preference when given alone, completely prevented place-preference induced by BW373U86 (1.0 mg/kg s.c.) and SNC 80 (1.25 mg/kg s.c.). The dopamine D-1 receptor antagonist SCH23390, given at doses that do not affect place-preference (0.012 mg/kg s.c.), completely prevented the place-preference induced by BW373U86 and SNC 80. At the doses effective in eliciting place-prefe...
The effect of interactions among mu- and delta-opioid receptors, especially the putative delta(1)- a...
HOFFMAN, D. C. AND R. J. BENINGER. The effects of selective dopamine D1 or D2 receptor antagonists o...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
The motivational properties of the non-peptide delta-opioid receptor agonists BW373U86 and SNC 80 we...
The unconditioned behavioural effects of two non-peptide delta-opioid receptor agonists, BW 373U86 a...
In unilaterally 6-hydroxydopamine lesioned rats the ability of two non-peptide delta-opioid agonists...
Both the reinforcing and aversive effects of exogenous opioids have been attributed to the activatio...
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors ...
The influence of the D1 antagonist SCH 23390 on the motivational properties of rewarding (morphine, ...
The delta opioid peptide (DOP) receptor has been proposed as a target in the symptomatic therapy of ...
The delta opioid peptide (DOP) receptor has been proposed as a target in the symptomatic therapy of ...
The motivational effects of dopamine (DA) D1 receptor blockade and its influence on the motivational...
The present study investigated the antidepressant-like effects of the nonpeptidic delta-opioid recep...
In the search for narcotic analgesic agents without the unwanted complications of mu-opioid receptor...
Opioid agonists having different affinity for delta and mu receptors were injected bilaterally in th...
The effect of interactions among mu- and delta-opioid receptors, especially the putative delta(1)- a...
HOFFMAN, D. C. AND R. J. BENINGER. The effects of selective dopamine D1 or D2 receptor antagonists o...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...
The motivational properties of the non-peptide delta-opioid receptor agonists BW373U86 and SNC 80 we...
The unconditioned behavioural effects of two non-peptide delta-opioid receptor agonists, BW 373U86 a...
In unilaterally 6-hydroxydopamine lesioned rats the ability of two non-peptide delta-opioid agonists...
Both the reinforcing and aversive effects of exogenous opioids have been attributed to the activatio...
Positive motivational properties of opioids, stimulants and serotonin selective reuptake inhibitors ...
The influence of the D1 antagonist SCH 23390 on the motivational properties of rewarding (morphine, ...
The delta opioid peptide (DOP) receptor has been proposed as a target in the symptomatic therapy of ...
The delta opioid peptide (DOP) receptor has been proposed as a target in the symptomatic therapy of ...
The motivational effects of dopamine (DA) D1 receptor blockade and its influence on the motivational...
The present study investigated the antidepressant-like effects of the nonpeptidic delta-opioid recep...
In the search for narcotic analgesic agents without the unwanted complications of mu-opioid receptor...
Opioid agonists having different affinity for delta and mu receptors were injected bilaterally in th...
The effect of interactions among mu- and delta-opioid receptors, especially the putative delta(1)- a...
HOFFMAN, D. C. AND R. J. BENINGER. The effects of selective dopamine D1 or D2 receptor antagonists o...
RATIONALE: A large body of evidence indicates an involvement of the mesolimbic dopamine (DA) pathway...